Symbol not found

NASDAQ:DYN   00:00AM GMT
0.00
0.00 (0.00%)
Earnings Announcements

Dyne Therapeutics Reports Q2 Loss Per Share Of $1.01

Published: 08/04/2022 12:28 GMT
Dyne Therapeutics Inc (DYN) - Dyne Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights.
Q2 Loss per Share $1.01.
Cash, Cash Equivalents and Marketable Securities is Anticipated to Fund Operations Into Second Half of 2024.
Q2 Earnings per Share View $-0.78 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.92

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.97

More details on our Analysts Page.